close
close

FINANCIAL REPORT FOR THE SECOND QUARTER AND HALF YEAR 2024


FINANCIAL REPORT FOR THE SECOND QUARTER AND HALF YEAR 2024

Hofseth Biocare ASA HBC generated gross operating revenue of NOK 80.4 million (76.4 million) in the second quarter and NOK 132.8 million (121.2 million) in the half year. Adjusted for asset sales in the second quarter, sales revenue for the quarter was NOK 72.2 million (50.7 million), an increase of 42 percent compared to the […]